Catapano Joshua S, Koester Stefan W, Srinivasan Visish M, Labib Mohamed A, Majmundar Neil, Nguyen Candice L, Rutledge Caleb, Cole Tyler S, Baranoski Jacob F, Ducruet Andrew F, Albuquerque Felipe C, Spetzler Robert F, Lawton Michael T
1Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona; and.
2Vanderbilt University School of Medicine, Nashville, Tennessee.
J Neurosurg. 2021 Oct 15;136(5):1245-1250. doi: 10.3171/2021.5.JNS211149. Print 2022 May 1.
Ophthalmic artery (OA) aneurysms are surgically challenging lesions that are now mostly treated using endovascular procedures. However, in specialized tertiary care centers with experienced neurosurgeons, controversy remains regarding the optimal treatment of these lesions. This study used propensity adjustment to compare microsurgical and endovascular treatment of unruptured OA aneurysms in experienced tertiary and quaternary settings.
The authors retrospectively reviewed the medical records of all patients who underwent microsurgical treatment of an unruptured OA aneurysm at the University of California, San Francisco, from 1997 to 2017 and either microsurgical or endovascular treatment at Barrow Neurological Institute from 2011 to 2019. Patients were categorized into two cohorts for comparison: those who underwent open microsurgical clipping, and those who underwent endovascular flow diversion or coil embolization. Outcomes included neurological or visual outcomes, residual or recurrent aneurysms, retreatment, and severe complications.
A total of 345 procedures were analyzed: 247 open microsurgical clipping procedures (72%) and 98 endovascular procedures (28%). Of the 98 endovascular procedures, 16 (16%) were treated with primary coil embolization and 82 (84%) with flow diversion. After propensity adjustment, microsurgical treatment was associated with higher odds of a visual deficit (OR 8.5, 95% CI 1.1-64.9, p = 0.04) but lower odds of residual aneurysm (OR 0.06, 95% CI 0.01-0.28, p < 0.001) or retreatment (OR 0.12, 95% CI 0.02-0.58, p = 0.008) than endovascular therapy. No difference was found between the two cohorts with regard to worse modified Rankin Scale score, modified Rankin Scale score greater than 2, or severe complications.
Compared with endovascular therapy, microsurgical clipping of unruptured OA aneurysms is associated with a higher rate of visual deficits but a lower rate of residual and recurrent aneurysms. In centers experienced with both open microsurgical and endovascular treatment of these lesions, the treatment choice should be based on patient preference and aneurysm morphology.
眼动脉(OA)动脉瘤是手术挑战性病变,目前大多采用血管内治疗。然而,在拥有经验丰富神经外科医生的专业三级医疗中心,对于这些病变的最佳治疗仍存在争议。本研究采用倾向调整方法,比较在经验丰富的三级和四级医疗机构中,未破裂OA动脉瘤的显微手术和血管内治疗。
作者回顾性分析了1997年至2017年在加利福尼亚大学旧金山分校接受未破裂OA动脉瘤显微手术治疗,以及2011年至2019年在巴罗神经学研究所接受显微手术或血管内治疗的所有患者的病历。患者被分为两个队列进行比较:接受开放性显微手术夹闭的患者,以及接受血管内血流导向或弹簧圈栓塞的患者。结果包括神经或视觉结果、残留或复发性动脉瘤、再次治疗和严重并发症。
共分析了345例手术:247例开放性显微手术夹闭(72%)和98例血管内手术(28%)。在98例血管内手术中,16例(16%)采用初次弹簧圈栓塞治疗,82例(84%)采用血流导向治疗。经过倾向调整后,显微手术治疗与视力缺损几率较高相关(比值比8.5,95%置信区间1.1 - 64.9,p = 0.04),但与残留动脉瘤(比值比0.06,95%置信区间0.01 - 0.28,p < 0.001)或再次治疗(比值比0.12,95%置信区间0.02 - 0.58,p = 0.008)几率较低相关。在两个队列之间,改良Rankin量表评分恶化、改良Rankin量表评分大于2或严重并发症方面未发现差异。
与血管内治疗相比,未破裂OA动脉瘤的显微手术夹闭与视力缺损发生率较高相关,但残留和复发性动脉瘤发生率较低。在对这些病变进行开放性显微手术和血管内治疗均有经验的中心,治疗选择应基于患者偏好和动脉瘤形态。